The report will be delivered in 2-3 business days.

Antivirals Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : October 2019 | SKU CODE : 7063 | Format :


The antivirals market consists of sales of antiviral drugs and related services. Antiviral drugs reduces the replication of viruses at different stages. Various type of viral infections for which antiviral drugs are used include HIV, herpes, hepatitis and influenza viruses.

The global antivirals market was valued at about $38.1 billion in 2018 and is expected to grow to $52.22 billion at a CAGR of 8.2% through 2022.

The antivirals market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The North American market is the largest market for antivirals and is expected to continue to be the largest market during the forecast period

The rising incidents of viral infections across the world is a significant driver for the antiviral drugs market. A virus is a small infectious agent which has the ability to invade a host cell and then grow in multiple numbers. Viruses can originate through various sources such as unhygienic living condition, change in weather or direct physical contact (body fluids and touch) with any host that is already infected with virus. According to UNAIDS, as of 2017, 36.9 million people were affected with HIV globally and out of those around 1.8 million people were affected with HIV in 2017.

The rising incidents of antiviral resistance is one of the major restraints for the antiviral drug market. Antiviral resistance occurs when viruses mutate and adapt to antiviral drugs due to prolonged usage of these drugs. The mutation changes that parts of the virus-cell that are affected by drugs, thus causing the antiviral drug to become ineffective against the virus. For example, in June 2017, the WHO (World Health Organization) removed Oseltamivir antiviral drug from the list of its essential medicines due to the drug's low effectiveness. Oseltamivir was used to cure flu virus (Influenza). Similarly, another class of drug, Adamantanes, which includes Amantadine (Symadine) and Rimantadine (Flumadine) were reported by CDC (Centers for Disease Control and Prevention) in the year 2017-18 as an ineffective medication, due to increase in resistance by Influenza A strains like H1N1 and H3N2 Viruses.

Pharmaceutical companies are increasingly using combination therapy to develop antiviral drugs to boost their effectiveness against viral infections. Combination therapy combines more than one medication for the treatment of the same condition. Combination therapy is beneficial in case if viral organisms like the influenza virus, develops resistance to a particular antiviral drug. However, it takes longer for the virus to develop resistance to a combination of drugs which are used together. In combination therapy, it is ensured that the viral infections are receptive to at least one of the drugs, which terminates replication and suppresses the infection. Combination therapy is especially helpful in the treatment of HIV as they help to combat the other infections which arise out of HIV. In 2018, Cocrystal Pharma, Inc., a biotechnology company which discovers and develops novel antiviral therapeutics, announced a Clinical Trial Agreement for investigator-initiated Phase 2a study of their new drug, CC-31244. This drug in combination with Sofosbuvir (direct acting antiviral medication used as part of combination therapy to treat chronic Hepatitis C) and Daclatasvir (medication used in synthesis with other medications to treat hepatitis C) will be used in the treatment of hepatitis C.

The Center for Drug Evaluation and Research, under Food and Drug Administration (FDA), provides guidance and recommendations for companies which manufacture antivirals drugs. For instance, under FDA guidance, the drugs for RHL (cold sores) undergo phase I safety studies, after which the proof-of-concept and dose-ranging are carried out in phase II studies. Finally, the drug has to undergo phase III superiority trials, which shows that one treatment is superior to another after which the approval is given.

Roche, a Swiss based pharmaceutical company, is set to acquire the US based Spark therapeutics, for USD 4.3 Billion. The deal is expected to be completed in June 2019. Roche through this acquisition will try to use gene therapy to develop new antivirals with high effectiveness. Spark, a US based biotechnology company, was found in 2013 and is widely popular due to advanced its advances in gene therapy drugs.

Major players in the market are Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc, Roche Holding AG and Gilead Sciences.

    1. Executive Summary

    2. Antivirals Market Characteristics

    3. Antivirals Market Size And Growth

    3.1. Global Antivirals Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Antivirals Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Antivirals Market Segmentation

    4.1. Global Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    HIV/AIDS Therapeutics

    Hepatitis (B & C) Therapeutics

    Herpes Therapeutics

    Influenza Therapeutics

    Others (Pneumonia)

    4.2. Global Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospitals

    Clinics

    Ambulatory surgical center

    4.3. Global Antivirals Market, Segmentation By Target, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    DNA polymerase

    NS3 Protease

    Reverse transcriptase

    Others

    4.4. Global Antivirals Market, Segmentation By Drug Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Generic

    Branded

    5. Antivirals Market Regional And Country Analysis

    5.1. Global Antivirals Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Antivirals Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Antivirals Market  

    6.1. Asia-Pacific Antivirals Market Overview  

    6.2. Asia-Pacific Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Antivirals Market  

    7.1. China Antivirals Market Overview  

    7.2. China Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Antivirals Market  

    8.1. India Antivirals Market Overview  

    8.2. India Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Antivirals Market  

    9.1. Japan Antivirals Market Overview  

    9.2. Japan Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Antivirals Market  

    10.1. Australia Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Antivirals Market  

    11.1. Indonesia Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Antivirals Market  

    12.1. South Korea Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Antivirals Market  

    13.1. Western Europe Antivirals Market Overview

    13.2. Western Europe Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Antivirals Market  

    14.1. UK Antivirals Market Overview

    14.2. UK Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Antivirals Market  

    15.1. Germany Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Antivirals Market  

    16.4. France Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.5. France Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Antivirals Market  

    17.1. Eastern Europe Antivirals Market Overview

    17.2. Eastern Europe Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Antivirals Market  

    18.1. Russia Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Antivirals Market  

    19.1. North America Antivirals Market Overview

    19.2. North America Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Antivirals Market  

    20.1. USA Antivirals Market Overview

    20.2. USA Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Antivirals Market  

    21.1. South America Antivirals Market Overview

    21.2. South America Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Antivirals Market  

    22.1. Brazil Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Antivirals Market  

    23.1. Middle East Antivirals Market Overview

    23.2. Middle East Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Antivirals Market  

    24.1. Africa Antivirals Market Overview

    24.2. Africa Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Antivirals Market Competitive Landscape And Company Profiles

    25.1. Antivirals Market Competitive Landscape

    25.2. Antivirals Market Company Profiles

    25.2.1. Merck & Co. Inc.

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Johnson & Johnson

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. GlaxoSmithKline Plc

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Roche Holding AG  

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Gilead Sciences

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Antivirals Market

    27. Antivirals Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Antivirals Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Antivirals Market, Segmentation By Target, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Antivirals Market, Segmentation By Drug Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Antivirals Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Global Antivirals Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: China, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: India, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: India, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: Japan, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: Japan, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Australia, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Australia, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Indonesia, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Indonesia, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: South Korea, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: South Korea, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Western Europe, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Western Europe, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: UK, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: UK, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: Germany, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: Germany, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: France, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: France, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Eastern Europe, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: Russia, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: Russia, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: North America, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: North America, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: USA, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: USA, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: South America, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: South America, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Brazil, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Brazil, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Middle East, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Middle East, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Africa, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Africa, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: Merck & Co. Inc. Financial Performance
  • Table 48: Johnson & Johnson Financial Performance
  • Table 49: GlaxoSmithKline Plc Financial Performance
  • Table 50: Roche Holding AG  Financial Performance
  • Table 51: Gilead Sciences Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Antivirals Market, Segmentation By Target, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Antivirals Market, Segmentation By Drug Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Antivirals Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Global Antivirals Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: China, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: India, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: India, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: Japan, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: Japan, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Australia, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Australia, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Indonesia, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: South Korea, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: South Korea, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Western Europe, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: UK, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: UK, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: Germany, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: Germany, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: France, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: France, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Eastern Europe, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: Russia, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: Russia, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: North America, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: North America, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: USA, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: USA, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: South America, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: South America, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Brazil, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Brazil, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Middle East, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Middle East, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Africa, Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Africa, Antivirals Market, Segmentation  By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: Merck & Co. Inc. Financial Performance
  • Figure 48: Johnson & Johnson Financial Performance
  • Figure 49: GlaxoSmithKline Plc Financial Performance
  • Figure 50: Roche Holding AG  Financial Performance
  • Figure 51: Gilead Sciences Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)